11/07/2013 18:45:00

U.K. Recalls Drugs Made in India

LONDON--In another sign of possible manufacturing problems in India's pharmaceutical industry, the U.K.'s medicines regulator said it was recalling 16 drugs made by Wockhardt Ltd. (532300.BY) after finding "manufacturing deficiencies" at one of the company's factories in India.

The Medicines and Healthcare products Regulatory Agency, or MHRA, called it a "precautionary recall," as there is no evidence that the medicines are defective. The agency said it is recalling the drugs from pharmacies and wholesalers but isn't asking patients to return their Wockhardt medicines.

"There is no evidence of a patient safety risk. ...however, the MHRA has to act in the interest of public health as poor manufacturing standards cannot be allowed to continue," the agency said.

The recalled drugs, manufactured in the central Indian city of Waluj, include treatments for infections, hypertension, diabetes, epilepsy and other diseases. The MHRA said the plant suffered from "poor cleaning practices" and defective ventilation systems. The agency inspection also found evidence of "forged documents relating to staff training records."

In an emailed statement, Wockhardt confirmed the news and said the recall would result in a one-time charge of 1.5 million pounds ($2.25 million) this year. Exports from the Waluj plant constitute less than 5% of the company's total U.K. sales and less than 2% of overall sales, it added.

It was the second recent setback for the company and its Waluj factory. In May, the U.S. Food and Drug Administration imposed an import ban on products from the factory after it failed an FDA safety inspection. The FDA didn't elaborate on the problems it found.

In a conference call at the time, Wockhardt Chairman Habil Khorakiwala said the company was implementing "corrective measures to be in compliance with the FDA guidelines." He said the U.S. import ban could cost the company $100 million in revenue this fiscal year. Wockhardt generated total revenue of 25.6 billion rupees ($460.6 million) in the year ended March 31, 2012.

Also in May, India's Ranbaxy Laboratories Ltd. (500359.BY) agreed to pay $500 million in civil and criminal fines for exporting adulterated drugs to the U.S.

In a phone interview Thursday, D.G. Shah, secretary-general of the Indian Pharmaceutical Alliance, an industry body, said the group has written to the FDA asking it to conduct workshops with Indian companies to correct erroneous practices.

"Companies need to better understand FDA processes, and there needs to be a correction in their organizational culture, right from drug discovery to development and production," Mr. Shah said.

Write to Jeanne Whalen at jeanne.whalen@wsj.com and Anirban Chowdhury at anirban.chowdhury@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

(END) Dow Jones Newswires

July 11, 2013 13:45 ET (17:45 GMT)

Copyright (c) 2013 Dow Jones & Company, Inc.

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
02 Dec
ZEAL
For en gangs skyld og kun denne ene gang svarer jeg dig.   Jeg anser dine indlæg omkring Zealand græ..
39
04 Dec
VWS
Det er lettere at se hvad DU ikke fatter. USA har, med et flertal af stemmer i kongressen, underskre..
29
05 Dec
NETS
Handles nu under kurs 115; absolut en af de mest pinlige IPOs i nyere dansk børs-historie.   Selskab..
26
03 Dec
VWS
Der er delte meninger om aktiekursen på Vestas. Vi har jo alle hver vores måde at vurdere virksomhed..
26
29 Nov
ZEAL
...når de investerer i mindre virksomheder og så vil ud hurtigt uanset at selskabet har fremgang og ..
21
04 Dec
 
Du forveksler din såkaldte anstændighed og ansvarlighed med naivitet og misforstået godhed. Grenen v..
18
02 Dec
ZEAL
Novo Nordisk og Zealand er nu med i den helt absolutte front i kombinations behandling af diabetes -..
18
05 Dec
 
Hej. Jeg kan se, at flere allerede er i gang med at skændes denne herlige mandag morgen. Jeg vil dog..
17
03 Dec
ZEAL
I ugens løb kom det frem, at Svenska Handelsbanken havde sænket anbefalingen på Zealand og at Aktieu..
17
29 Nov
 
Følgende artikel giver et godt indblik i at ledende danske politikere har større interesser i at mel..
16

Appointment of Joint Corporate Broker

05/12/2016 15:00:33
Appointment of Joint Corporate Broker Stagecoach Group plc is pleased to announce that RBC Capital Markets has been appointed Joint Corporate Brok..

Rathbones : Form 8.3 - [Alternative Networks PLC]

05/12/2016 12:06:02
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE ..

HSBC Bank Plc : Form 8.5 (EPT/RI) - Brammer PLC

05/12/2016 10:32:18
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Bristol is Open Wins Internet of Things Award for Programmable City Initiative
2
Form 8 (OPD) - Alternative Networks plc
3
The Eye Doctors Host an Event on December 7 to Celebrate the Launch of Their Men’s Premier Red Bull Eyewear Line
4
Form 8.5 (EPT/RI) - Alternative Networks plc - AMENDMENT
5
Karyopharm Presents Updated Phase 1b STOMP Data at the American Society of Hematology 2016 Annual Meeting

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2016   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
06 December 2016 10:16:04
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20161205.1 - EUROWEB1 - 2016-12-06 11:16:04 - 2016-12-06 10:16:04 - 1000 - Website: OKAY